Search Results - "Jones, Laney K"

International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia by Watts, Gerald F., Gidding, Samuel S., Hegele, Robert A., Raal, Frederick J., Sturm, Amy C., Jones, Laney K., Sarkies, Mitchell N., Al-Rasadi, Khalid, Blom, Dirk J., Daccord, Magdalena, de Ferranti, Sarah D., Folco, Emanuela, Libby, Peter, Mata, Pedro, Nawawi, Hapizah M., Ramaswami, Uma, Ray, Kausik K., Stefanutti, Claudia, Yamashita, Shizuya, Pang, Jing, Thompson, Gilbert R., Santos, Raul D.

“…This contemporary, international, evidence-informed guidance aims to achieve the greatest good for the greatest number of people with familial…”
Get full text

Statin Intolerance: an Overview of US and International Guidance by Cheeley, Mary Katherine, Clegg, Katarina, Lockridge, Connor, Schubert, Tyler J., Jones, Laney K.

“…Purpose of Review To review recent international and domestic definitions, considerations, and treatment algorithms for statin intolerance, and specifically,…”
Get full text

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment by Jones, Laney K, Sturm, Amy C, Seaton, Terry L, Gregor, Christina, Gidding, Samuel S, Williams, Marc S, Rahm, Alanna Kulchak

“…Familial hypercholesterolemia (FH) is an inherited lipid disorder that confers high risk for premature cardiovascular disease but remains undertreated. Causes…”
Get full text

Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events by Tecson, Kristen M., Kluger, Aaron Y., Cassidy-Bushrow, Andrea E., Liu, Bin, Coleman, Chad M., Jones, Laney K., Jefferson, Celeena R., VanWormer, Jeffrey J., McCullough, Peter A.

“…Clinical guidelines recommend statins for patients with atherosclerotic cardiovascular disease (ASCVD), but many remain untreated. The goal of this study was…”
Get full text

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis by Jones, Laney K, Tilberry, Stephanie, Gregor, Christina, Yaeger, Lauren H, Hu, Yirui, Sturm, Amy C, Seaton, Terry L, Waltz, Thomas J, Rahm, Alanna K, Goldberg, Anne, Brownson, Ross C, Gidding, Samuel S, Williams, Marc S, Gionfriddo, Michael R

“…Numerous implementation strategies to improve utilization of statins in patients with hypercholesterolemia have been utilized, with varying degrees of success…”
Get full text

Evaluating implementation outcomes (acceptability, adoption, and feasibility) of two initiatives to improve the medication prior authorization process by Jones, Laney K, Ladd, Ilene G, Gregor, Christina, Evans, Michael A, Graham, Jove, Gionfriddo, Michael R

“…Processes such as prior authorization (PA) for medications, implemented by health insurance companies to ensure that safe, appropriate, cost-effective, and…”
Get full text

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia by Campbell-Salome, Gemme, Jones, Laney K, Walters, Nicole L, Morgan, Kelly M, Brangan, Andrew, Ladd, Ilene G, McGowan, Mary P, Wilemon, Katherine, Schmidlen, Tara J, Simmons, Emilie, Schwartz, Marci L B, McMinn, Megan N, Tricou, Eric, Rahm, Alanna K, Ahmed, Catherine D, Sturm, Amy C

“…This project aimed to optimize communication strategies to support family communication about familial hypercholesterolemia (FH) and improve cascade testing…”
Get full text

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia by Agarwala, Anandita, Bekele, Nathan, Deych, Elena, Rich, Michael W, Hussain, Aliza, Jones, Laney K, Sturm, Amy C, Aspry, Karen, Nowak, Elizabeth, Ahmad, Zahid, Ballantyne, Christie M, Goldberg, Anne C

“…Background Black men and women are at higher risk for, and suffer greater morbidity and mortality from, atherosclerotic cardiovascular disease (ASCVD) compared…”
Get full text

International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia by Watts, Gerald F, Jones, Laney K, Sarkies, Mitchell N, Pang, Jing, Gidding, Samuel S, Libby, Peter, Santos, Raul D

“…Familial hypercholesterolaemia (FH), a common monogenic disorder, is a preventable cause of premature coronary artery disease and death. Up to 35 million…”
Get full text

A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System by Jones, Laney K, Strande, Natasha T, Calvo, Evan M, Chen, Jingheng, Rodriguez, Gabriela, McCormick, Cara Z, Hallquist, Miranda L G, Savatt, Juliann M, Rocha, Heather, Williams, Marc S, Sturm, Amy C, Buchanan, Adam H, Glasgow, Russell E, Martin, Christa L, Rahm, Alanna Kulchak

“…DNA-based population screening has been proposed as a public health solution to identify individuals at risk for serious health conditions who otherwise may…”
Get full text

Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening by Gidding, Samuel S, Kirchner, H Lester, Brangan, Andrew, Howard, William, Kelly, Melissa A, Myers, Kelly D, Morgan, Kelly M, Oetjens, Matthew T, Shuey, Timothy C, Staszak, David, Strande, Natasha T, Walters, Nicole L, Yu, Kristen D, Wilemon, Katherine A, Williams, Marc S, Sturm, Amy C, Jones, Laney K

“…Background Data mining of electronic health records to identify patients suspected of familial hypercholesterolemia (FH) has been limited by absence of both…”
Get full text

Hidden Burden of Electronic Health Record-Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care by Patel, Prashant, Hu, Yirui, Kolinovsky, Amy, Geng, Zhi, Ruhl, Jeffrey, Krishnamurthy, Sarath, deRichemond, Caroline, Khan, Ayesha, Kirchner, H Lester, Metpally, Raghu, Jones, Laney K, Sturm, Amy C, Carey, David, Snyder, Susan, Williams, Marc S, Mehra, Vishal C

“…Background Familial hypercholesterolemia ( FH ), is a historically underdiagnosed, undertreated, high-risk condition that is associated with a high burden of…”
Get full text

Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis by Jones, Laney K, McMinn, Megan, Kann, David, Lesko, Michael, Sturm, Amy C, Walters, Nicole, Chen, Nan, Fry, Kerrianne, Brownson, Ross C, Gidding, Samuel S, Williams, Marc S, Rahm, Alanna Kulchak

“…Individuals with complex dyslipidemia, or those with medication intolerance, are often difficult to manage in primary care. They require the additional…”
Get full text

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study by Walters, Nicole L., Lindsey-Mills, Zoe T., Brangan, Andrew, Savage, Sarah K., Schmidlen, Tara J., Morgan, Kelly M., Tricou, Eric P., Betts, Megan M., Jones, Laney K., Sturm, Amy C., Campbell-Salome, Gemme

“…To assess use of two web-based conversational agents, the Family Sharing Chatbot (FSC) and One Month Chatbot (OMC), by individuals with familial…”
Get full text

IMPACT-FH Study for Implementing Innovative Family Communication and Cascade Testing Strategies for Familial Hypercholesterolemia by Jones, Laney K., Campbell-Salome, Gemme, Walters, Nicole L., Brangan, Andrew, Morgan, Kelly M., Tricou, Eric P., Lindsey Mills, Zoe T., McGowan, Mary P., Gidding, Samuel S., Johns, Alicia M., Kirchner, H. Lester, Rahm, Alanna Kulchak, Sturm, Amy C.

“…Relatives of probands diagnosed with familial hypercholesterolemia (FH) should undergo cascade testing for FH. The purpose of this study was to evaluate…”
Get full text

Patient experiences align with the familial hypercholesterolemia global call to action by Jones, Laney K., Walters, Nicole, Brangan, Andrew, Ahmed, Catherine D., Wilemon, Katherine A., Campbell-Salome, Gemme, Rahm, Alanna K., Gidding, Samuel S., Sturm, Amy C.

“…To explore alignment of perspectives from individuals and families with familial hypercholesterolemia (FH) to the FH Global Call to Action recommendations…”
Get full text

Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia by Jones, Laney K, Kulchak Rahm, Alanna, Manickam, Kandamurugu, Butry, Loren, Lazzeri, Amanda, Corcoran, Timothy, Komar, Daniel, Josyula, Navya S, Pendergrass, Sarah A, Sturm, Amy C, Murray, Michael F

“…The MyCode Community Health Initiative (MyCode) is returning actionable results from whole exome sequencing. Familial hypercholesterolemia (FH) is an inherited…”
Get full text

Improving clinical practice guidelines with implementation science by Sarkies, Mitchell N., Jones, Laney K., Gidding, Samuel S., Watts, Gerald F.

“…Clinical practice guidelines provide evidence-informed recommendations to improve the delivery of high-quality health care. Despite their ubiquity, the…”
Get full text

Translating guidelines into practice via implementation science: an update in lipidology by Jones, Laney K., Sturm, Amy C., Gionfriddo, Michael R.

“…Guidelines provide recommendations for clinicians based on the best available evidence and informed by clinical expertise. These recommendations often fail to…”
Get full text

Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis by Guzauskas, Gregory F, Garbett, Shawn, Zhou, Zilu, Schildcrout, Jonathan S, Graves, John A, Williams, Marc S, Hao, Jing, Jones, Laney K, Spencer, Scott J, Jiang, Shangqing, Veenstra, David L, Peterson, Josh F

“…The cost-effectiveness of screening the U.S. population for Centers for Disease Control and Prevention (CDC) Tier 1 genomic conditions is unknown. To estimate…”
Get full text